Creating new molecules to treat cancer and infectious diseases
Synthesis and Study of Medicinally Important Molecules
This study is looking at new ways to create helpful medicines that could treat serious illnesses like cancer and infections that don't respond to regular drugs, with the hope of finding better treatments for patients.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Emory University NIH-funded |
| Lab location | 1 site (Atlanta, United States) |
| Project ID | NIH-10888151 on NIH RePORTER |
What this research studies
This research focuses on developing innovative methods for synthesizing both natural and synthetic molecules that have the potential to treat serious health conditions like cancer and drug-resistant infections. By exploring the biology of these molecules, the researchers aim to understand how they work and improve their effectiveness as treatments. Patients may benefit from new therapies that arise from this work, which could lead to better outcomes for those suffering from these diseases.
Who could benefit from this research
Good fit: Ideal candidates for this research are patients with cancer, neurological disorders, or drug-resistant infectious diseases.
Not a fit: Patients with conditions unrelated to cancer, neurological disorders, or infectious diseases may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to the development of new and effective treatments for cancer and drug-resistant infections.
How similar studies have performed: Other research has shown success in developing new therapies through innovative synthesis methods, indicating a promising approach.
Where this research is happening
Atlanta, United States
- Emory University — Atlanta, United States (Active)
Researchers
- Principal investigator: Dai, Mingji — Emory University
- Study coordinator: Dai, Mingji
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.